Newton, MA, United States of America

Carmen Bozic

This inventor holds 8 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Biogen Ma Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carmen Bozic. Retrieved from https://idiyas.com/inventor/carmen-bozic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Carmen Bozic: Innovator in Neurological Risk Assessment

Introduction

Carmen Bozic is a prominent inventor based in Newton, MA (US). He has made significant contributions to the field of neurology, particularly in assessing risks associated with Progressive multifocal leukoencephalopathy (PML). With a total of 8 patents to his name, Bozic's work has the potential to impact the treatment of multiple sclerosis patients.

Latest Patents

Among his latest patents, Bozic has developed a method of assessing the risk of PML. This invention focuses on evaluating a patient's likelihood of developing this serious condition. Additionally, he has created methods for treating multiple sclerosis patients with anti-VLA-4 therapy, further enhancing the understanding and management of PML risks.

Career Highlights

Carmen Bozic is currently associated with Biogen MA Inc., a leading biotechnology company. His work at Biogen has allowed him to collaborate with other experts in the field, contributing to innovative solutions for neurological disorders.

Collaborations

Some of his notable coworkers include Gary Lewis Bloomgren and Sophia Lee, who have worked alongside him in advancing research and development in neurology.

Conclusion

Carmen Bozic's contributions to the field of neurology through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative methods for assessing and treating PML risk are paving the way for advancements in multiple sclerosis care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…